Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy
暂无分享,去创建一个
[1] J. Martínez-Suárez,et al. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans , 1995, Journal of clinical microbiology.
[2] M. Rinaldi,et al. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing , 1995, Journal of clinical microbiology.
[3] J. Rex,et al. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group , 1995, Antimicrobial agents and chemotherapy.
[4] M. Trautmann,et al. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection , 1994, Journal of clinical microbiology.
[5] M. Pfaller,et al. Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole , 1994, Journal of clinical microbiology.
[6] A. Espinel-Ingroff. Etest for antifungal susceptibility testing of yeasts. , 1994, Diagnostic microbiology and infectious disease.
[7] M. Rinaldi,et al. In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus , 1994, Antimicrobial Agents and Chemotherapy.
[8] M. Pfaller,et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] M. Pfaller,et al. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans , 1994, Journal of clinical microbiology.
[10] M. Pfaller,et al. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis , 1994, Journal of clinical microbiology.
[11] J. Rex,et al. Antifungal Susceptibility Testing of Isolates from a Randomized, Multicenter Trial of Fluconazole versus Amphotericin B as Treatment of Nonneutropenic Patients with Candidemia , 1994 .
[12] J. Perfect,et al. Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1 , 1993, Antimicrobial Agents and Chemotherapy.
[13] J. Galgiani,et al. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests , 1992, Journal of clinical microbiology.
[14] T. Walsh,et al. Standardized susceptibility testing of fluconazole: an international collaborative study , 1992, Antimicrobial Agents and Chemotherapy.
[15] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.